Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Protein kinase C and lipid signaling for sustained cellular responses
The MHRA has not licensed AOD 9604 as a medicinal product in the UK, and its status can be confirmed via the MHRA's product licence search
Accessed July, 2025
The implication for clinical practice is that restoring youthful MOTS-c signaling might be a mechanistically legitimate target for longevity intervention
Another Example: Lower Dose Scenario: Same vial (10 mg + 2 ml BAC = 5 mg/ml)
Long-term safety: Published human studies extend to 12 weeks maximum
US$ 27.78
US$ 29.00
US$ 24.22
US$ 26.34
US$ 27.21
